Citations

Showing 10 of 108081 citations.

Do Polygenic Scores Inform Psychiatric Disease Risk After Considering Family History?
Biernacka, Joanna M.

Mayo Clinic

American Journal of Psychiatry | April 1, 2023 | Volume: 180 | Issue: 4 | Pages: 256-258

10.1176/appi.ajp.20230116 | PMID 37002695 Get It

The devil is in the details: Understanding how misinformation regarding epilepsy manifests in TikTok videos
Jiang, Kallie, Nordli, Douglas R. , Galán, Fernando , Galan, Fernando N , Nordli Iii, Douglas R

Mayo Clinic

Epileptic Disorders | April 1, 2023 | Volume: 25 | Issue: 1 | Pages: 28-32

10.1002/epd2.20036 | PMID 37002554 Get It

AbstractObjectiveThis study sought to understand the amount of misinformation surrounding epilepsy on the social media platform, TikTok.MethodsVideos from TikTok were searched using keyword “epilepsy.” In all, 109 videos were categorized as personal experience videos, event videos, or educational videos. Misinformation surrounding each video was analyzed by two independent reviewers. The number of videos and views of each were tracked.ResultsEvent videos garnered the most attention (80% of total views). Of the event videos, 26/47 contained misinformation in the form of calling a nonepileptic event an epileptic seizure (55%). Videos of nonepileptic events labeled as epileptic seizures amassed 109 956 400 views.SignificanceThis novel study quantifies the amount of misinformation regarding epilepsy on the social media platform, TikTok. The results showcase that misinformation is very prevalent on the application. Most of the misinformation consists of the mislabeling of nonepileptic events as epileptic seizures. Physicians should be aware of cardinal features of nonepileptic events to better treat patients. The medical community must understand the type of misinformation people are exposed to in order to educate patients appropriately.
The nephrotoxicity of bortezomib: did we miss a complication after 20 years of use and multiple landmark trials?
Chowdhury, Raad , Chowdhury, Raad B, Kastritis, Efstathios , Rajkumar, S. Vincent , Leung, Nelson

Mayo Clinic

Nephrology Dialysis Transplantation | April 1, 2023 | Volume: 38 | Issue: 10 | Pages: 2099-2104

10.1093/ndt/gfad061 | PMID 37002539 Get It

Prolonged Fever in a 3-year-old Girl
Zhu, Agnes , Tran, Cheryl L. , Said, Samar M. , Gregory, Seth W. , Zhu, Agnes Q

Mayo Clinic

Pediatrics In Review | April 1, 2023 | Volume: 44 | Issue: 4 | Pages: 228-231

10.1542/pir.2021-005159 | PMID 37002356 Get It

Implementing a Unit-Based Alarm Management Bundle for Critical Care Nurses
Bosma, Stephanie, Christopher, Roberta

Mayo Clinic

Critical Care Nurse | April 1, 2023 | Volume: 43 | Issue: 2 | Pages: 36-45

10.4037/ccn2023418 | PMID 37001877 Get It

BackgroundClinical alarms are designed to signal an unsatisfactory patient physiological state and alert staff members to malfunctioning medical equipment. Alarm desensitization and fatigue can occur when clinicians are exposed to an overwhelming number of clinical alarms, particularly nonactionable alarms.Local ProblemAlarm fatigue and alarm management competency related to use of Philips monitoring systems were noted to be problematic among nurses working in the 27-bed surgical intensive care unit of a teaching hospital in northeastern Florida.MethodsA quality improvement project was conducted to reduce alarm fatigue and improve nursing competency in managing alarms. The CEASE (Communication, Electrodes, Appropriateness, Setup, and Education) evidence-based alarm management bundle was implemented on the unit, and a representative from the alarm manufacturer conducted in-service training sessions. A clinical alarms survey developed by the Healthcare Technology Foundation was distributed both before and after the intervention to 115 nurses working in the unit. Descriptive and inferential statistics were used to assess for differences between the preintervention and postintervention periods.ResultsNurse participants demonstrated improved alarm management competency, resulting in significant improvements in their perceptions of alarm functionality, settings, response time, and policy adherence. There was a statistically significant decrease in self-reported alarm fatigue, and the CEASE bundle was found to influence nursing practice.ConclusionsThe Joint Commission’s 2022 goal of improving clinical alarm safety remains a top priority nationwide. Implementation of the CEASE alarm management bundle was effective in reducing surgical intensive care unit nurses’ alarm fatigue and improving their alarm management practices.
Evaluation of the Educational Value of Low-Cost Training Model for Emergency Cricothyrotomy
Nour, Mohammad Ghasemi , Sadrzadeh, Sayyed Majid , Assadi, Reza , AlJamal, Yazan N, Assadi, Reza , Moradi, Elnaz Vafadar , AlJamal, Yazan , Arghami, Arman

Mayo Clinic

Surgical Innovation | March 31, 2023 | Volume: 30 | Issue: 3 | Pages: 383-389

10.1177/15533506231162992 | PMID 37002547 Get It

Background In this study, we aimed to evaluate the educational value and students’ satisfaction with the hand-made low-cost cricothyrotomy simulation model. Materials and Methods A low-cost and hand-made model and a high-fidelity model were used to assess the students. The students’ knowledge and satisfaction were evaluated using a 10-item checklist and a satisfaction questionnaire, respectively. Medical interns in the present study participated in a two-hour briefing and debriefing session held in the Clinical Skills Training Center by an emergency attending doctor. Results Based on the results of data analysis, no significant differences were found between the two groups in terms of gender, age, the month of internship, and last semester’s grade ( P = .628, .356, .847, and .421, respectively). We also found no significant differences between our groups in terms of the median score of each item in the assessment checklist ( P = .838, .736, .805, .172, .439, .823, .243, .950, .812, and .756, respectively). The study groups had no significant difference in the median total scores of the checklist as well ( P = .504). Regarding the students’ satisfaction, our results showed that interns evaluated their experience of the model as positive (median scores of 4 and 5 out of 5). They also gave the hand-made model a median score of 7 in comparison with the high-fidelity model and 8 out of 10 for its usability. Conclusion The study results showed that a low-cost model could be as effective as an expensive high-fidelity model for teaching the necessary knowledge of cricothyrotomy techniques to medical trainees.
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma
Kottschade, Lisa A. , Pond, Gregory R. , Olszanski, Anthony J. , Zakharia, Yousef , Domingo‐Musibay, Evidio , Hauke, Ralph J. , Curti, Brendan D. , Schober, Sarah , Milhem, Mohammed , Block, Matthew S. , Pond, Gregory Russell , Milhem, Mohammed M , Block, Matthew S , Hieken, Tina J , McWilliams, Robert R , Olszanski, Anthony J , Zakharia, Yousef , Hieken, Tina J. , McWilliams, Robert R.

Mayo Clinic

Clinical Cancer Research | March 31, 2023 | Volume: 29 | Issue: 12 | Pages: 2220-2225

10.1158/1078-0432.ccr-22-3207 | PMID 37000165 Get It

Abstract Purpose: Mucosal melanoma is a rare, aggressive form of melanoma with extremely high recurrence rates despite definitive surgical resection with curative intent. Currently there is no consensus on adjuvant therapy. Data on checkpoint inhibitors for adjuvant therapy are lacking. Patients and Methods: We performed a single-arm, multicenter clinical trial using “flip dose” ipilimumab (1 mg/kg q3w × 4 cycles), and nivolumab (3 mg/kg q3w × 4 cycles), then nivolumab 480 mg q4w × 11 cycles to complete a year of adjuvant therapy. Participants must have had R0/R1 resection ≤90 days before registration, no prior systemic therapy (adjuvant radiotherapy allowed), ECOG 0/1, and no uncontrolled autoimmune disease or other invasive cancer. Patients were recruited through the Midwest Melanoma Partnership/Hoosier Oncology Network. Results: From September 2017 to August 2021, 35 patients were enrolled. Of these, 29 (83%) had R0 resections, and 7 (20%) received adjuvant radiotherapy. Median age was 67 years, 21 (60.0%) female. Recurrence-free survival (RFS) rates at 1 and 2 years were 50% [95% confidence interval (CI), 31%–66%] and 37% (95% CI, 19%–55%), respectively. Overall survival rates at 1 and 2 years were 87% (95% CI, 68%–95%) and 68% (95% CI, 46%–83%), respectively. Median RFS was 10.3 months (95% CI, 5.7–25.8). Most common grade 3 toxicities were diarrhea (14%), hypertension (14%), and hyponatremia (11%), with no grade 4/5 toxicities. Conclusions: Flip-dose ipilimumab and nivolumab after resection of mucosal melanoma is associated with outcomes improved over that of surgical resection alone. Long-term follow-up, subgroup analyses and correlative studies are ongoing.
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma
Westin, Jason R. , Locke, Frederick L. , Dickinson, Michael , Ghobadi, Armin , Elsawy, Mahmoud , Meerten, Tom van , Miklos, David B. , Ulrickson, Matthew L. , Perales, Miguel‐Angel , Farooq, Umar , Leslie, Lori A. , Kersten, Marie José , Jacobson, Caron A. , Pagel, John M. , Wulf, Gerald , Johnston, Patrick B. , Rapoport, Aaron P. , Du, Linqiu , Vardhanabhuti, Saran , Filosto, Simone , Shah, Jina , Snider, Julia Thornton , Cheng, Paul , To, Christina , Oluwole, Olalekan O. , Sureda, Anna , van Meerten, Tom , Wannesson, Luciano , Leslie, Lori , Kersten, Marie José , Jacobson, Caron A , Pagel, John M , Wulf, Gerald , Johnston, Patrick , Rapoport, Aaron P , Du, Linqiu , Vardhanabhuti, Saran , Filosto, Simone , Shah, Jina , Snider, Julia T , Cheng, Paul , To, Christina , Oluwole, Olalekan O , Sureda, Anna , Farooq, Umar , Perales, Miguel-Angel , Miklos, David B , Westin, Jason R , Dickinson, Michael , Ghobadi, Armin , Locke, Frederick L

Mayo Clinic

Clinical Cancer Research | March 31, 2023 | Volume: 29 | Issue: 10 | Pages: 1894-1905

10.1158/1078-0432.ccr-22-3136 | PMID 36999993 Get It

Abstract Purpose: Older patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) may be considered ineligible for curative-intent therapy including high-dose chemotherapy with autologous stem-cell transplantation (HDT-ASCT). Here, we report outcomes of a preplanned subgroup analysis of patients ≥65 years in ZUMA-7. Patients and Methods: Patients with LBCL refractory to or relapsed ≤12 months after first-line chemoimmunotherapy were randomized 1:1 to axicabtagene ciloleucel [axi-cel; autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy] or standard of care (SOC; 2–3 cycles of chemoimmunotherapy followed by HDT-ASCT). The primary endpoint was event-free survival (EFS). Secondary endpoints included safety and patient-reported outcomes (PROs). Results: Fifty-one and 58 patients aged ≥65 years were randomized to axi-cel and SOC, respectively. Median EFS was greater with axi-cel versus SOC (21.5 vs. 2.5 months; median follow-up: 24.3 months; HR, 0.276; descriptive P < 0.0001). Objective response rate was higher with axi-cel versus SOC (88% vs. 52%; OR, 8.81; descriptive P < 0.0001; complete response rate: 75% vs. 33%). Grade ≥3 adverse events occurred in 94% of axi-cel and 82% of SOC patients. No grade 5 cytokine release syndrome or neurologic events occurred. In the quality-of-life analysis, the mean change in PRO scores from baseline at days 100 and 150 favored axi-cel for EORTC QLQ-C30 Global Health, Physical Functioning, and EQ-5D-5L visual analog scale (descriptive P < 0.05). CAR T-cell expansion and baseline serum inflammatory profile were comparable in patients ≥65 and <65 years. Conclusions: Axi-cel is an effective second-line curative-intent therapy with a manageable safety profile and improved PROs for patients ≥65 years with R/R LBCL.
Is dorsal root entry zone lesioning effective and safe for managing continuous versus paroxysmal pains post–brachial plexus avulsion?
Pennington, Zach , Ochuba, Arinze , Khalifeh, Jawad M. , Al‐Mistarehi, Abdel‐Hameed , Belzberg, Allan J., Pennington, Zach , Lubelski, Daniel

Mayo Clinic

Journal of Neurosurgery: Spine | March 31, 2023 | Volume: 39 | Issue: 1 | Pages: 101-112

10.3171/2023.2.spine221252 | PMID 37021771 Get It

OBJECTIVE Patients with brachial plexus avulsion (BPA) experience chronic deafferentation pain characterized by two patterns: continuous background pain and electrical shooting paroxysmal attacks. The authors’ aim was to report the effectiveness and safety of dorsal root entry zone (DREZ) lesioning in relieving the two forms of pain over short and long periods. METHODS All patients who underwent DREZ lesioning performed by the senior author for medically refractory BPA-related pain between July 1, 2016, and June 30, 2020, in Johns Hopkins Hospital were followed up. The intensity levels for continuous and paroxysmal pains were evaluated using the numeric rating scale (NRS) preoperatively and at 4 time points postsurgery, including the day of discharge, with a mean hospital stay of 5.6 ± 1.8 days; first postoperative clinic visit (33.0 ± 15.7 days); short-term follow-up (4.0 ± 1.4 months); and long-term follow-up (3.1 ± 1.3 years). The percent of pain relief according to the NRS was categorized into excellent (≥ 75%), fair (25%–74%), and poor (< 25%). RESULTS A total of 19 patients were included, with 4 (21.1%) lost to long-term follow-up. The mean age was 52.7 ± 13.6 years; 16 (84.2%) were men, and 10 (52.6%) had left-sided injuries. A motor vehicle accident was the most common etiology of BPA (n = 16, 84.2%). Preoperatively, all patients had motor deficits, and 8 (42.1%) experienced somatosensory deficits. The greatest pain relief was observed at the first postoperative and short-term follow-up visits, with the lowest proportions of patients having continuous pain (26.3% and 23.5%, respectively) and paroxysmal pain (5.3% and 5.9%, respectively). Also, the highest reductions in mean NRS scores were observed for first postoperative and short-term follow-up visits (continuous 1.1 ± 2.1 and 1.1 ± 2.3; paroxysms 0.4 ± 1.4 and 0.5 ± 1.7, respectively) compared to the preoperative symptomatology (continuous 6.7 ± 3.0; paroxysms 7.9 ± 4.3) (p < 0.001). Most patients had excellent relief of continuous pain (82.4% and 81.3%) and of paroxysms (90.9% and 90.0%) at the first postoperative visit and short-term follow-up visit, respectively. The pain relief benefits had diminished by 3 years after surgery but remained significantly better than in the preoperative assessment. At the last evaluation, the proportion of patients achieving excellent relief of paroxysmal pain (66.7%) was double that for continuous pain (35.7%) (p < 0.001). New sensory phenomena were observed among 10 patients (52.6%), and 1 patient developed a motor deficit. CONCLUSIONS DREZ lesioning is an effective and safe option for relieving BPA-associated pain, with good long-term outcomes and better benefits for paroxysmal pain than for the continuous pain component.
Do comorbid self-reported depression and anxiety influence outcomes following surgery for cervical spondylotic myelopathy?
Chan, Andrew K. , Shaffrey, Christopher I. , Park, Christine , Gottfried, Oren N., Than, Khoi D. , Bisson, Erica F. , Bydon, Mohamad , Asher, Anthony L. , Coric, Domagoj , Potts, Eric A. , Foley, Kevin T. , Wang, Michael Y. , Fu, Kai-Ming, Virk, Michael S. , Knightly, John J. , Meyer, Scott A., Park, Paul , Upadhyaya, Cheerag D., Shaffrey, Mark E., Buchholz, Avery L., Tumialán, Luis M. , Turner, Jay D. , Michalopoulos, Giorgos D. , Sherrod, Brandon A. , Agarwal, Nitin , Chou, Dean , Haid, Regis W., Mummaneni, Praveen V. , Michalopoulos, Giorgos

Mayo Clinic

Journal of Neurosurgery: Spine | March 31, 2023 | Volume: 39 | Issue: 1 | Pages: 11-27

10.3171/2023.2.spine22685 | PMID 37021762 Get It

OBJECTIVE Depression and anxiety are associated with inferior outcomes following spine surgery. In this study, the authors examined whether patients with cervical spondylotic myelopathy (CSM) who have both self-reported depression (SRD) and self-reported anxiety (SRA) have worse postoperative patient-reported outcomes (PROs) compared with patients who have only one or none of these comorbidities. METHODS This study is a retrospective analysis of prospectively collected data from the Quality Outcomes Database CSM cohort. Comparisons were made among patients who reported the following: 1) either SRD or SRA, 2) both SRD and SRA, or 3) neither comorbidity at baseline. PROs at 3, 12, and 24 months (scores for the visual analog scale [VAS] for neck pain and arm pain, Neck Disability Index [NDI], modified Japanese Orthopaedic Association [mJOA] scale, EQ-5D, EuroQol VAS [EQ-VAS], and North American Spine Society [NASS] patient satisfaction index) and achievement of respective PRO minimal clinically important differences (MCIDs) were compared. RESULTS Of the 1141 included patients, 199 (17.4%) had either SRD or SRA alone, 132 (11.6%) had both SRD and SRA, and 810 (71.0%) had neither. Preoperatively, patients with either SRD or SRA alone had worse scores for VAS neck pain (5.6 ± 3.1 vs 5.1 ± 3.3, p = 0.03), NDI (41.0 ± 19.3 vs 36.8 ± 20.8, p = 0.007), EQ-VAS (57.0 ± 21.0 vs 60.7 ± 21.7, p = 0.03), and EQ-5D (0.53 ± 0.23 vs 0.58 ± 0.21, p = 0.008) than patients without such disorders. Postoperatively, in multivariable adjusted analyses, baseline SRD or SRA alone was associated with inferior improvement in the VAS neck pain score and a lower rate of achieving the MCID for VAS neck pain score at 3 and 12 months, but not at 24 months. At 24 months, patients with SRD or SRA alone experienced less change in EQ-5D scores and were less likely to meet the MCID for EQ-5D than patients without SRD or SRA. Furthermore, patient self-reporting of both psychological comorbidities did not impact PROs at all measured time points compared with self-reporting of only one psychological comorbidity alone. Each cohort (SRD or SRA alone, both SRD and SRA, and neither SRD nor SRA) experienced significant improvements in mean PROs at all measured time points compared with baseline (p < 0.05). CONCLUSIONS Approximately 12% of patients who underwent surgery for CSM presented with both SRD and SRA, and 29% presented with at least one symptom. The presence of either SRD or SRA was independently associated with inferior scores for 3- and 12-month neck pain following surgery, but this difference was not significant at 24 months. However, at long-term follow-up, patients with SRD or SRA experienced lower quality of life than patients without SRD or SRA. The comorbid presence of both depression and anxiety was not associated with worse patient outcomes than either diagnosis alone.